{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:42:00Z","timestamp":1788892920432,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Myocardial fibrosis is associated with a poor outcome for patients with cardiovascular disease (CVD). Growth differentiation factor 15 (GDF-15) concentrations predict the risk of death in patients with CVD, but the underlying pathophysiological mechanisms are poorly understood. We aimed to assess the associations between biomarkers of cellular stress and inflammation (GDF-15), cardiac injury (cardiac troponin T [cTnT]), and stretch (N-terminal pro-B-type natriuretic peptide [NT-proBNP]), and subsequent focal and diffuse myocardial fibrosis assessed by cardiac magnetic resonance (CMR) imaging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We measured GDF-15, cTnT, and NT-proBNP in 200 study participants without known coronary artery disease or renal dysfunction from the population-based Akershus Cardiac Examination 1950 Study at baseline in 2012 to 2015. Focal myocardial scars and diffuse fibrosis were assessed by late gadolinium enhancement imaging and septal extracellular volume fraction (ECV) by CMR 4 to 7 years later. The relationships between cardiac biomarkers and CMR parameters were assessed by logistic regression analysis adjusted for common cardiovascular risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The median age was 63.9 (interquartile range 63.4\u201364.5) years and 49% were women. GDF-15 (adjusted odds ratio [aOR] 4.40, 95% CI 1.09\u201317.72) and cTnT (aOR 1.59, 95% CI 1.01\u20132.50) were associated with nonischemic scars in the fully adjusted model. cTnT (aOR 2.45, 95% CI 1.41\u20134.25) and NT-proBNP (aOR 3.12, 95% CI 1.55\u20136.28) were associated with ischemic scars. None of the biomarkers were significantly associated with elevated ECV.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In a general population cohort, GDF-15, an emerging biomarker of cellular stress and inflammation, associates with nonischemic scars. Biomarkers of myocardial injury and stretch associate with ischemic scars, while no biomarker was associated with diffuse fibrosis as assessed by CMR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jalm\/jfae145","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T05:16:52Z","timestamp":1734758212000},"page":"392-405","source":"Crossref","is-referenced-by-count":4,"title":["Associations between Growth Differentiation Factor 15, Cardiac Troponin T, and N-terminal pro-B-type Natriuretic Peptide, and Future Myocardial Fibrosis Assessed by Cardiac Magnetic Resonance Imaging: Data from the Akershus Cardiac Examination 1950 Study"],"prefix":"10.1093","volume":"10","author":[{"given":"Thakshani","family":"Wimalanathan","sequence":"first","affiliation":[{"name":"Department of Diagnostic Imaging, Division of Diagnostics and Technology, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]},{"name":"K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9434-7485","authenticated-orcid":false,"given":"Michael Fredrik","family":"Paus","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Department of Cardiology, Division of Medicine, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Brox Skranes","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve","family":"Berge","sequence":"additional","affiliation":[{"name":"Department of Medical Research, B\u00e6rum Hospital, Vestre Viken Hospital Trust , Gjettum ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnljot","family":"Tveit","sequence":"additional","affiliation":[{"name":"Department of Medical Research, B\u00e6rum Hospital, Vestre Viken Hospital Trust , Gjettum ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"R\u00f8sj\u00f8","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Akershus Clinical Research Center (ACR), Division of Research and Innovation, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f8rn","family":"Omland","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Department of Cardiology, Division of Medicine, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5994-9304","authenticated-orcid":false,"given":"Magnus Nakrem","family":"Lyngbakken","sequence":"additional","affiliation":[{"name":"K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Department of Cardiology, Division of Medicine, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Lagethon Heck","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Division of Diagnostics and Technology, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]},{"name":"K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"2025072811264920700_jfae145-B1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jchf.2022.12.005","article-title":"Reclassification of pre-heart failure stages using cardiac biomarkers: the ARIC study","volume":"11","author":"Jia","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2025072811264920700_jfae145-B2","first-page":"488","article-title":"Biomarkers for heart failure prediction and prevention","volume":"10","author":"Kotta","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"2025072811264920700_jfae145-B3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcmg.2011.11.011","article-title":"Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the cardiovascular health study","volume":"5","author":"Kalogeropoulos","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025072811264920700_jfae145-B4","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcmg.2019.05.033","article-title":"The interstitium in the hypertrophied heart","volume":"12","author":"Halliday","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025072811264920700_jfae145-B5","doi-asserted-by":"crossref","first-page":"926378","DOI":"10.3389\/fcvm.2022.926378","article-title":"Detection of myocardial fibrosis: where we stand","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025072811264920700_jfae145-B6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12968-018-0484-5","article-title":"Society for cardiovascular magnetic resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I\u2014analytical validation and clinical qualification","volume":"20","author":"Puntmann","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025072811264920700_jfae145-B7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcmg.2019.03.017","article-title":"Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1","volume":"13","author":"Treibel","year":"2020","journal-title":"JACC-Cardiovasc Imag"},{"key":"2025072811264920700_jfae145-B8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ehjci\/jeac010","article-title":"Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the multi-ethnic study of atherosclerosis","volume":"23","author":"Marques","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025072811264920700_jfae145-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-18-S1-O61","article-title":"Prevalence and prognosis of non-ischemic patterns of late gadolinium enhancement in older adults by cardiovascular MR in the ICELAND-MI study","volume":"18","author":"Shanbhag","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025072811264920700_jfae145-B10","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/CIRCULATIONAHA.112.129437","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study","volume":"126","author":"Wang","year":"2012","journal-title":"Circulation"},{"key":"2025072811264920700_jfae145-B11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth differentiation factor 15 as a biomarker in cardiovascular disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin Chem"},{"key":"2025072811264920700_jfae145-B12","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/CIRCULATIONAHA.116.025505","article-title":"High-sensitive cardiac troponin T as an early biochemical signature for clinical and subclinical heart failure: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"135","author":"Seliger","year":"2017","journal-title":"Circulation"},{"key":"2025072811264920700_jfae145-B13","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.jacc.2017.10.044","article-title":"Association of elevated NT-proBNP with myocardial fibrosis in the multi-ethnic study of atherosclerosis (MESA)","volume":"70","author":"Liu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025072811264920700_jfae145-B14","doi-asserted-by":"crossref","first-page":"e019243","DOI":"10.1161\/JAHA.120.019243","article-title":"Association of pro-b-type natriuretic peptide with cardiac magnetic resonance-measured global and regional cardiac function and structure over 10 years: the MESA study","volume":"10","author":"Rahsepar","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025072811264920700_jfae145-B15","doi-asserted-by":"crossref","first-page":"1104715","DOI":"10.3389\/fcvm.2023.1104715","article-title":"Association of cardiac troponin t and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The Multi-Ethnic Study of Atherosclerosis","volume":"10","author":"deFilippi","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2025072811264920700_jfae145-B16","first-page":"308","article-title":"Heart and brain interactions-the akershus cardiac examination (ACE) 1950 study design","volume":"49","author":"Berge","year":"2015","journal-title":"Scand Cardiovasc J"},{"key":"2025072811264920700_jfae145-B17","doi-asserted-by":"crossref","first-page":"e021704","DOI":"10.1136\/bmjopen-2018-021704","article-title":"Prevalence of atrial fibrillation and cardiovascular risk factors in a 63\u201365 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 study","volume":"8","author":"Berge","year":"2018","journal-title":"BMJ Open"},{"key":"2025072811264920700_jfae145-B18","first-page":"356","article-title":"Prediction of incident atrial fibrillation with cardiac biomarkers and left atrial volumes","volume":"109","author":"Lyngbakken","year":"2023","journal-title":"Heart"},{"key":"2025072811264920700_jfae145-B19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025072811264920700_jfae145-B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12968-021-00827-z","article-title":"Society for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations","volume":"24","author":"Hundley","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025072811264920700_jfae145-B21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025072811264920700_jfae145-B22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ehjci\/jeac242","article-title":"Emerging molecular imaging targets and tools for myocardial fibrosis detection","volume":"24","author":"Barton","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025072811264920700_jfae145-B23","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2009.04.094","article-title":"The role of cardiovascular magnetic resonance imaging in heart failure","volume":"54","author":"Karamitsos","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2025072811264920700_jfae145-B24","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1515\/cclm-2022-0135","article-title":"Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort","volume":"60","author":"Welsh","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2025072811264920700_jfae145-B25","doi-asserted-by":"crossref","first-page":"e024668","DOI":"10.1161\/JAHA.121.024668","article-title":"Characteristics associated with growth differentiation factor 15 in heart failure with preserved ejection fraction and the impact of pirfenidone","volume":"11","author":"Lewis","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025072811264920700_jfae145-B26","first-page":"100046","article-title":"Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: potential role in cardiovascular diseases","volume":"9","author":"di Candia","year":"2021","journal-title":"Am Heart J Plus"},{"key":"2025072811264920700_jfae145-B27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"Bibbins-Domingo","year":"2007","journal-title":"JAMA"},{"key":"2025072811264920700_jfae145-B28","doi-asserted-by":"crossref","first-page":"10.18103\/mra.v8i2.2039","DOI":"10.18103\/mra.v8i2.2039","article-title":"NT-proBNP level predicts extent of myonecrosis and clinical adverse outcomes in patients with ST-elevation myocardial infarction: a pilot study","volume":"8","author":"Mathbout","year":"2020","journal-title":"Med Res Arch"},{"key":"2025072811264920700_jfae145-B29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MCA.0b013e328342c72e","article-title":"Unrecognized myocardial scars detected by delayed-enhanced MRI are associated with increased levels of NT-proBNP","volume":"22","author":"Themudo","year":"2011","journal-title":"Coron Artery Dis"},{"key":"2025072811264920700_jfae145-B30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","article-title":"Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches","volume":"18","author":"L\u00f3pez","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2025072811264920700_jfae145-B31","first-page":"88","article-title":"Correlation between growth differentiation factor-15 and collagen metabolism indicators in patients with myocardial infarction and heart failure","volume":"13","author":"Wang","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"2025072811264920700_jfae145-B32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/eurjhf\/hfs120","article-title":"Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support","volume":"14","author":"Lok","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2025072811264920700_jfae145-B33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","article-title":"Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: from the EMPA-TROPISM study","volume":"9","author":"Requena-Ibanez","year":"2021","journal-title":"JACC Heart Fail"},{"key":"2025072811264920700_jfae145-B34","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat Med"},{"key":"2025072811264920700_jfae145-B35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/1354750X.2018.1490969","article-title":"Possible mechanisms behind cardiac troponin elevations","volume":"23","author":"Hammarsten","year":"2018","journal-title":"Biomarkers"},{"key":"2025072811264920700_jfae145-B36","first-page":"553","article-title":"How is cardiac troponin released from injured myocardium?","volume":"7","author":"Mair","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2025072811264920700_jfae145-B37","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/CIRCULATIONAHA.120.046574","article-title":"Temporal release of high-sensitivity cardiac troponin t and i and copeptin after brief induced coronary artery balloon occlusion in humans","volume":"143","author":"\u00c1rnad\u00f3ttir","year":"2021","journal-title":"Circulation"},{"key":"2025072811264920700_jfae145-B38","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans: a scientific statement from the American Heart Association","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"key":"2025072811264920700_jfae145-B39","doi-asserted-by":"crossref","first-page":"e010262","DOI":"10.1161\/CIRCHEARTFAILURE.122.010262","article-title":"Myocardial fibrosis and cardiomyopathy risk: a genetic link in the MESA","volume":"16","author":"Shabani","year":"2023","journal-title":"Circ Heart Fail"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/10\/2\/392\/61250898\/jfae145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/10\/2\/392\/61250898\/jfae145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T15:26:56Z","timestamp":1753716416000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/10\/2\/392\/7930002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12,21]]},"published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfae145","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,12,21]]}}}